Inadequate supply of vitamins and DHA in the elderly: implications for brain aging and Alzheimer-type dementia (Q26828385)

Barbara Troesch

series ordinal

2

1 reference

Peter Weber

series ordinal

3

1 reference

language of work or name

1 reference

February 2015

1 reference

1 reference

31

1 reference

PubMed

issue

2

1 reference

PubMed

page(s)

261-75

1 reference

A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II.

PubMed

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Folate, vitamin B12, and serum total homocysteine levels in confirmed Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

A family with spinocerebellar ataxia type 8 expansion and vitamin E deficiency ataxia

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin E and cognitive decline in older persons

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Alzheimer Disease in the US Population

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Relation of higher folate intake to lower risk of Alzheimer disease in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Prevalence of vitamin d insufficiency in patients with Parkinson disease and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Docosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Effect of vitamin E and memantine on functional decline in Alzheimer disease: the TEAM-AD VA cooperative randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

The underestimated potential of the immune system in prevention of Alzheimer's disease pathology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Cognitive and clinical outcomes of homocysteine-lowering B-vitamin treatment in mild cognitive impairment: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Chemistry and biology of vitamin E

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin E and neurological function

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin D3 enhances mood in healthy subjects during winter

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Abnormal amino acid metabolism in patients with early stage Alzheimer dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Hyperhomocysteinemia in dementia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

A cross-sectional study of homocysteine-, NO-levels, and CT-findings in Alzheimer dementia, vascular dementia and controls.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Genetic, epigenetic and posttranslational mechanisms of aging

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Indices of metabolic dysfunction and oxidative stress

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Dietary folate, vitamin B-12, vitamin B-6 and incident Alzheimer's disease: the cache county memory, health and aging study

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Dopamine-beta-hydroxylase

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Homocysteine in Alzheimer disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Plasma homocysteine levels and cognitive status in long-term stay geriatric patients: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Menatetrenone and vitamin D2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Relations between homocysteine, folate and vitamin B12 in vascular dementia and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Prognostic impact of disease-related malnutrition

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

A life course of adiposity and dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Nucleic acid oxidation in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Rapid resolution of delusional parasitosis in pellagra with niacin augmentation therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Older adults who use vitamin/mineral supplements differ from nonusers in nutrient intake adequacy and dietary attitudes

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Reduced risk of Alzheimer's disease with high folate intake: the Baltimore Longitudinal Study of Aging

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

2011 Alzheimer's disease facts and figures

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Effect of an antioxidant drink on homocysteine levels in Alzheimer's patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Does senescence give rise to disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin D and neurocognitive dysfunction: preventing "D"ecline?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Dietary supplementation of arachidonic and docosahexaenoic acids improves cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Aging and excitotoxic stress exacerbate neural circuit reorganization in amyloid precursor protein intracellular domain transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Tocopherols and tocotrienols plasma levels are associated with cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Anti-aβ therapeutics in Alzheimer's disease: the need for a paradigm shift

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Telomere shortening in elderly individuals with mild cognitive impairment may be attenuated with ω-3 fatty acid supplementation: a randomized controlled pilot study

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

The effects of omega-3 fatty acids monotherapy in Alzheimer's disease and mild cognitive impairment: a preliminary randomized double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Tau aggregation into fibrillar polymers: taupathies

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Plasma total homocysteine levels and the C677T mutation in the methylenetetrahydrofolate reductase (MTHFR) gene: a study in an Italian population with dementia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

The role of alpha-tocopherol in preventing disease: from epidemiology to molecular events

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

1 reference

7 January 2021

Vitamin E: non-antioxidant roles

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin E and its function in membranes

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Anti-apoptotic wild-type Alzheimer amyloid precursor protein signaling involves the p38 mitogen-activated protein kinase/MEF2 pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

The state versus amyloid-beta: the trial of the most wanted criminal in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Amyloid-beta: a (life) preserver for the brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Plasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin nutrition in older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Food intake in the real world: implications for nutrition and aging

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Alzheimer's disease: clinical trials and drug development

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Is antioxidant use protective of cognitive function in the community-dwelling elderly?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Effects of n-3 fatty acids, EPA v. DHA, on depressive symptoms, quality of life, memory and executive function in older adults with mild cognitive impairment: a 6-month randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Dietary surveys indicate vitamin intakes below recommendations are common in representative Western countries

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Weight loss and Alzheimer's disease: temporal and aetiologic connections

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Alzheimer's disease: development of disease-modifying treatments is the challenge for our generation

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Approaches toward new Alzheimer's treatments

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamins - wrong approaches

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Gene regulation and DNA damage in the ageing human brain

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Fish consumption, long-chain omega-3 fatty acids and risk of cognitive decline or Alzheimer disease: a complex association.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Alzheimer's researchers call for clinical revamp.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Resolving controversies on the path to Alzheimer's therapeutics

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Subacute sensory ataxia and optic neuropathy with thiamine deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Eating well: ageing gracefully!

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Serum levels of beta-carotene, alpha-carotene and vitamin A in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Low micronutrient intake may accelerate the degenerative diseases of aging through allocation of scarce micronutrients by triage

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Preventing Alzheimer's disease-related gray matter atrophy by B-vitamin treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Appraising the brain's energy budget

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L- carnitine and/or R-alpha -lipoic acid

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Oxidative damage and mitochondrial decay in aging

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Low serum cholesteryl ester-docosahexaenoic acid levels in Alzheimer's disease: a case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

The North/South Ireland Food Consumption Survey: vitamin intakes in 18-64-year-old adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Medial temporal lobe atrophy, apolipoprotein genotype, and plasma homocysteine in Sri Lankan patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin C as an antioxidant: evaluation of its role in disease prevention

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

An Aging World--demographics and challenges

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Reduced gastrointestinal absorption of calcium in dementia.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Osteoporosis and the role of vitamin D and calcium-vitamin D deficiency, vitamin D insufficiency and vitamin D sufficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin E may affect the life expectancy of men, depending on dietary vitamin C intake and smoking

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Nutritional factors in physical and cognitive functions of elderly people

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Dietary intake and cognitive function in a group of elderly people.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The third National Health and Nutrition Examination Survey, 1988-1994.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Relation of the tocopherol forms to incident Alzheimer disease and to cognitive change

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Multivitamin-multimineral supplements: who uses them?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Plasma vitamin B-6 forms and their relation to transsulfuration metabolites in a large, population-based study

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Failure to modulate attentional control in advanced aging linked to white matter pathology

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Dementia prevention: methodological explanations for inconsistent results

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Is metabolic evidence for vitamin B-12 and folate deficiency more frequent in elderly patients with Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Association of plasma homocysteine in elderly persons with atherosclerotic vascular disease and dementia, atherosclerotic vascular disease without dementia, dementia without atherosclerotic vascular disease, and no dementia or atherosclerotic vascul

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Higher vitamin D dietary intake is associated with lower risk of alzheimer's disease: a 7-year follow-up

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

B vitamins, cognition, and aging: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

A cost constraint alone has adverse effects on food selection and nutrient density: an analysis of human diets by linear programming

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

The Hordaland Homocysteine Study: a community-based study of homocysteine, its determinants, and associations with disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin E: function and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Nutritional status of free-living Alzheimer's patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Gut changes attributed to ageing: effects on intestinal microflora

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin D, neurocognitive functioning and immunocompetence

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Neuropathological alterations in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

A critical evaluation of the relationship between serum vitamin B, folate and total homocysteine with cognitive impairment in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin D and cognitive performance in adults: a systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Antibody-based approaches in Alzheimer's research: safety, pharmacokinetics, metabolism, and analytical tools

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Fundic atrophic gastritis in an elderly population. Effect on hemoglobin and several serum nutritional indicators.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Bone density, vitamin D nutrition, and parathyroid hormone levels in women with dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

An Index of Food Quality

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

What is an adequate dose of oral vitamin B12 in older people with poor vitamin B12 status?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Neurodevelopment and neurodegeneration: are there critical stages for nutritional intervention?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

1 reference

7 January 2021

Current concepts in cobalamin deficiency

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Plasma folate, vitamin B(12), and total homocysteine and homozygosity for the C677T mutation of the 5,10-methylene tetrahydrofolate reductase gene in patients with Alzheimer's dementia. A case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Cobalamin, folate, methylmalonic acid, homocysteine, and gastritis markers in dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Plasma homocysteine, cobalamin/folate status, and vascular disease in a large population of psychogeriatric patients.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Calcium metabolism in Alzheimer's disease. A case-control study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Serum vitamin D deficiency as a predictor of incident non-Alzheimer dementias: a 7-year longitudinal study.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Alpha-tocopherol induces expression of connective tissue growth factor and antagonizes tumor necrosis factor-alpha-mediated downregulation in human smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Moderately elevated plasma homocysteine, methylenetetrahydrofolate reductase genotype, and risk for stroke, vascular dementia, and Alzheimer disease in Northern Ireland

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

The influence of micronutrients on cognitive function and performance

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

The role of vitamins and minerals in energy metabolism and well-being

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Cognitive findings of an exploratory trial of docosahexaenoic acid and lutein supplementation in older women.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Preclinical Alzheimer disease: identification of cases at risk among cognitively intact older individuals

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Alzheimer's disease: synapses gone cold

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Biological aging is no longer an unsolved problem

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Advanced glycation end product level, diabetes, and accelerated cognitive aging

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Age and diagnostic performance of Alzheimer disease CSF biomarkers.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Homocysteine, vitamin B6, and vascular disease in AD patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Treatment of vitamin b(12)-deficiency anemia: oral versus parenteral therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Vitamin B12 (cobalamin) deficiency in elderly patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Homocysteine, vitamin B12 and folate in vascular dementia and in Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Homocysteine and B vitamins in mild cognitive impairment and dementia

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Abeta deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Targeting astrocytes ameliorates neurologic changes in a mouse model of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Cognitive profile of amyloid burden and white matter hyperintensities in cognitively normal older adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Amyloid-independent mechanisms in Alzheimer's disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Alzheimer's disease in Brazilian elderly has a relation with homocysteine but not with MTHFR polymorphisms.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Oxidation as "the stress of life".

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Omega-3 fatty acids: potential role in the management of early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

The role of iron and copper in the aetiology of neurodegenerative disorders: therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Cognitive and cardiovascular benefits of docosahexaenoic acid in aging and cognitive decline

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Antioxidants in health, disease and aging

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Ascorbic Acid and Reaction Kinetics in situ: A New Approach to Vitamin Requirements

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Reactive Oxygen Species Mediate Cellular Damage in Alzheimer Disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease elevated levels of tau in cerebrospinal fluid: implications for the antemortem diagnosis of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

High fruit and vegetable intake is positively correlated with antioxidant status and cognitive performance in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

High plasma levels of vitamin E forms and reduced Alzheimer's disease risk in advanced age.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Neuronutrition and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Homocysteine, vitamin B12, and folic acid levels in Alzheimer's disease, mild cognitive impairment, and healthy elderly: baseline characteristics in subjects of the Australian Imaging Biomarker Lifestyle study

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

The effects of multivitamins on cognitive performance: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

A critical review of vitamin C for the prevention of age-related cognitive decline and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Dietary intakes of vitamin E, vitamin C, and β-carotene and risk of Alzheimer's disease: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Low serum vitamin D concentrations in Alzheimer's disease: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Intake of selected nutrients from foods, from fortification and from supplements in various European countries.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Monitoring of vitamin B-12 nutritional status in the United States by using plasma methylmalonic acid and serum vitamin B-12.

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Residency and specialties training in nutrition: a call for action

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Multivitamin use and telomere length in women

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Serum phospholipid docosahexaenonic acid is associated with cognitive functioning during middle adulthood

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Foods, fortificants, and supplements: Where do Americans get their nutrients?

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Increased autophagic degradation of mitochondria in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Effects of folic acid supplementation on hearing in older adults: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Long-term multivitamin supplementation and cognitive function in men: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021

Enough is enough: Stop wasting money on vitamin and mineral supplements

1 reference

https://api.crossref.org/works/10.1016%2FJ.NUT.2014.06.016

7 January 2021